NCT03029702View on ClinicalTrials.gov

Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

February 28, 2018

Primary Completion Date

August 31, 2023

Study Completion Date

August 31, 2023

Conditions
Gestational DiabetesDiabetes, GestationalPregnancy in Diabetes
Interventions
DRUG

Insulin

Insulin will be used for GDM treatment

DRUG

Glyburide

Glyburide will be used for GDM treatment

DRUG

Metformin

Metformin will be used for GDM treatment

Trial Locations (1)

15213

Magee Womens Hospital of UPMC, Pittsburgh

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Maisa N. Feghali, MD

OTHER

NCT03029702 - Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus | Biotech Hunter | Biotech Hunter